Charta Health Raises $55M Series B for AI Chart Review
TL;DR: Total funding is now $85 million, per the company. No source states a valuation or a revenue base. What did Charta Health announce? Charta raised $55 million in a Series B led by Insight Partn…

What did Charta Health announce?
Charta raised $55 million in a Series B led by Insight Partners. According to the company's release on PR Newswire, that brings total funding to $85 million and makes it Charta's third round in under two years.
The money has two stated uses. Charta will put it toward further AI development and the formal launch of two business units, Charta for Providers and Charta for Payers. Behavioral Health Business adds that part of it will extend the provider product into new specialties, including mental health.
| Round | Amount | Lead | Date |
|---|---|---|---|
| Seed | $8.1M | Not stated in sources | 2025 |
| Series A | $22M | Not stated in sources | 2025 |
| Series B | $55M | Insight Partners | November 10, 2026 |
The seed and Series A figures come from MobiHealthNews, which dates both to last year. Together with the Series B, they roughly add up to the $85 million total the company reports.
What does Charta's product actually do?
Charta reads medical charts with AI before a claim is billed. According to HIT Consultant, the software checks the documentation against official ICD-10-CM and CPT coding guidelines, commercial payer medical policies, and local institutional protocols.
The company's pitch is a shared standard. HIT Consultant describes it as resolving discrepancies before claims are sent rather than arguing over them after. Founders Justin Liu (CEO) and Scott Morris (CTO) previously worked at Rockset, and the company says they earned Certified Professional Coder credentials before building the product.
What does the revenue claim tell you?
Very little by itself. The company says it "grew revenue 10x in the last 12 months," but no source gives the starting revenue, the current revenue or the customer count, so you cannot size the business at all. A 10x increase from a small base is a different business than 10x from a large one.
The company names American Family Care, Grow Therapy and Pediatric Associates Family of Companies as enterprise clients. That shows real buyers exist. It does not show how much any of them spend.
What is not disclosed?
No source cited here states a valuation for this round, or the stake Insight Partners took. Downside first: without an entry price you can't judge how much has to go right. If you see a valuation in circulation, ask where it came from. Our coverage of Neko Health's Series C shows why a reported valuation and a negotiated one can differ.
Who else is raising in this market?
Charta isn't the only company funded to automate healthcare billing work. MobiHealthNews notes that Arintra raised $25 million in Series B funding earlier this year.
That tells you investors are backing several bets at once. The sources don't say how Charta compares with Arintra on customers or pricing, so the round alone can't tell you whether Charta is the leader. For another back-office automation raise, see Outmarket AI's Series B.
What does this mean for accredited investors?
You cannot buy Charta stock through this announcement. The round is a private financing led by an institutional firm, which means no public market, no daily quote and no easy exit if you ever end up holding a piece through a vehicle. If exposure is offered through a feeder fund or SPV, the questions are the usual ones. What are the fees, what is the entry valuation, and what is the lockup?
The round is evidence of investor demand for AI in healthcare billing. It is not evidence of returns. Venture outcomes follow a power law, and a company that raises three rounds quickly can still stall. Verify before you trust. Our Tractian Series D piece read that company's valuation as its own stated figure rather than a filing, and Charta's 10x claim deserves the same reading: a company's number until someone else confirms it.
Common mistakes
The first is mixing up names. Carta Healthcare is a separate company in clinical data management, and its own release is about that company, not Charta's round.
The second is quoting the growth multiple without a base. The third is treating a lead investor's name as due diligence, when Insight Partners backing a company tells you only that Insight did its own work. It does not let you skip yours.
FAQ
Who led Charta Health's Series B?
Insight Partners led the $55 million round. Existing investors Madrona, Bain Capital Ventures and South Park Commons took part, along with QuantumLight, according to the company's release.
How much has Charta Health raised in total?
The company reports $85 million across three rounds.
What will Charta do with the money?
It will fund AI research and development and launch Charta for Providers and Charta for Payers. Behavioral Health Business reports that part of it will also take the provider product into new specialties, including mental health.
Can individual investors buy into Charta?
Nothing in the announcement offers shares to individuals. It describes a private round with institutional leadership. Any outside offer of exposure needs its own fee, valuation and liquidity review.
One thing to do today
Open the company's release and write down what it does not say, starting with valuation and revenue base. Then subscribe to the free AIN briefing, where we flag the missing numbers when the next healthcare AI round lands.
Educational content only. Not investment, tax, or legal advice. Not an offer or solicitation to buy or sell securities. Past performance does not guarantee future results. Private-market investments are illiquid and involve risk of loss, including total loss of capital. Consult qualified advisers. Angel Investors Network is not a broker-dealer or investment adviser.
Looking for investors?
Browse our directory of 750+ angel investor groups, VCs, and accelerators across the United States.
About the Author
Jeff Barnes, MBAContinue Reading

Luminoah Raises $25M Series B for Tube Feeding Pump

American AI Logistics Closes Series B Led by GOVO

Venture Capital Investors: Who They Are, Who They Fund

SC Ventures and SBI Join Soter Insure's Series B

Team USA Seeks Private Investment in New Venture
